Harry van Dijken

910 total citations
22 papers, 718 citations indexed

About

Harry van Dijken is a scholar working on Epidemiology, Microbiology and Immunology. According to data from OpenAlex, Harry van Dijken has authored 22 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 11 papers in Microbiology and 6 papers in Immunology. Recurrent topics in Harry van Dijken's work include Influenza Virus Research Studies (11 papers), Bacterial Infections and Vaccines (11 papers) and Pneumonia and Respiratory Infections (9 papers). Harry van Dijken is often cited by papers focused on Influenza Virus Research Studies (11 papers), Bacterial Infections and Vaccines (11 papers) and Pneumonia and Respiratory Infections (9 papers). Harry van Dijken collaborates with scholars based in Netherlands, Russia and United States. Harry van Dijken's co-authors include Peter van der Ley, Betsy Kuipers, Germie van den Dobbelsteen, Mathieu Streefland, René H. Wijffels, Leo van der Pol, Bas van de Waterbeemd, Dirk E. Martens, Bert Zomer and Loek van Alphen and has published in prestigious journals such as PLoS ONE, Journal of Virology and Science Advances.

In The Last Decade

Harry van Dijken

21 papers receiving 682 citations

Peers

Countries citing papers authored by Harry van Dijken

Since Specialization

Citations

This map shows the geographic impact of Harry van Dijken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry van Dijken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry van Dijken more than expected).

Fields of papers citing papers by Harry van Dijken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry van Dijken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry van Dijken. The network helps show where Harry van Dijken may publish in the future.

Co-authorship network of co-authors of Harry van Dijken

This figure shows the co-authorship network connecting the top 25 collaborators of Harry van Dijken. A scholar is included among the top collaborators of Harry van Dijken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry van Dijken. Harry van Dijken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Memory-CD8+-T-Cell Response to Conserved Influenza Virus Epitopes in Mice Is Not Influenced by Time Since Previous Infection 2024 ·Vaccines ·(unknown), (unknown), (unknown), Harry van Dijken, (unknown), Martijn Vos, José A. M. Borghans, Debbie van Baarle, Jørgen de Jonge	0
2	Modified influenza M158–66 peptide vaccination induces non-relevant T-cells and may enhance pathology after challenge 2023 ·npj Vaccines ·(unknown), (unknown), Harry van Dijken, (unknown), (unknown), (unknown), Paul Roholl, José A. M. Borghans, Debbie van Baarle, Jørgen de Jonge	2
3	A universal influenza mRNA vaccine candidate boosts T cell responses and reduces zoonotic influenza virus disease in ferrets 2022 ·Science Advances ·(unknown), (unknown), Harry van Dijken, Hiromi Muramatsu, (unknown), (unknown), (unknown), Mitchell Beattie, Paulo J.C. Lin, José A. Ferreira, Judith M. A. van den Brand, Debbie van Baarle, Norbert Pardi, Jørgen de Jonge	27
4	Influenza Infection in Ferrets with SARS-CoV-2 Infection History 2022 ·Microbiology Spectrum ·(unknown), (unknown), Harry van Dijken, (unknown), (unknown), Lisa Wijsman, (unknown), (unknown), Puck B. van Kasteren, Judith M. A. van den Brand, Jørgen de Jonge	3
5	Varying Viral Replication and Disease Profiles of H2N2 Influenza in Ferrets Is Associated with Virus Isolate and Inoculation Route 2022 ·Journal of Virology ·(unknown), Harry van Dijken, Wenjuan Du, (unknown), (unknown), Sanne Spijkers, Sharon van den Brink, Paul Roholl, Cornelis A. M. de Haan, Jørgen de Jonge	1
6	Pathology and Immunity After SARS-CoV-2 Infection in Male Ferrets Is Affected by Age and Inoculation Route 2021 ·Frontiers in Immunology ·(unknown), Harry van Dijken, Lisa Wijsman, (unknown), (unknown), Jolanda Kool, (unknown), Paul Roholl, Adam Meijer, Puck B. van Kasteren, Jørgen de Jonge	23
7	Systemic and respiratory T-cells induced by seasonal H1N1 influenza protect against pandemic H2N2 in ferrets 2020 ·Communications Biology ·(unknown), (unknown), Harry van Dijken, José A. Ferreira, Jørgen de Jonge	13
8	H7N9 influenza split vaccine with SWE oil-in-water adjuvant greatly enhances cross-reactive humoral immunity and protection against severe pneumonia in ferrets 2020 ·npj Vaccines ·Jørgen de Jonge, Harry van Dijken, (unknown), Sanne Spijkers, (unknown), Rineke de Jong, Paul Roholl, (unknown), (unknown), Paulo Lee Ho, Livia Brunner, Nicolas Collin, Martin Friede, José A. Ferreira, Willem Luytjes	21
9	H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets 2016 ·Molecular Therapy ·Jørgen de Jonge, Irina Isakova–Sivak, Harry van Dijken, Sanne Spijkers, (unknown), Rineke de Jong, (unknown), Paul Roholl, Larisa Rudenko	28
10	Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets 2015 ·PLoS ONE ·Sietske K. Rosendahl Huber, Marcel Camps, Ronald Jacobi, (unknown), Harry van Dijken, Josine van Beek, Ferry Ossendorp, Jørgen de Jonge	32
11	Expression of human CEACAM1 in transgenic mice limits the Opa-specific immune response against meningococcal outer membrane vesicles 2013 ·Vaccine ·(unknown), Harry van Dijken, Hendrik-Jan Hamstra, Michiel van der Flier, Gestur Vidarsson, Jos P. M. van Putten, Claire J. P. Boog, Germie van den Dobbelsteen, Peter van der Ley	11
12	Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process 2010 ·Vaccine ·Bas van de Waterbeemd, Mathieu Streefland, Peter van der Ley, Bert Zomer, Harry van Dijken, Dirk E. Martens, René H. Wijffels, Leo van der Pol	150
13	Heterologous prime-boost strategy to overcome weak immunogenicity of two serosubtypes in hexavalent Neisseria meningitidis outer membrane vesicle vaccine 2005 ·Vaccine ·(unknown), Harry van Dijken, (unknown), (unknown)	12
14	Antibody Specificities and Effect of Meningococcal Carriage in Icelandic Teenagers Receiving the Norwegian Serogroup B Outer Membrane Vesicle Vaccine 2003 ·Infection and Immunity ·Elisabeth Wedege, Betsy Kuipers, (unknown), Harry van Dijken, L O Frøholm, Clementien L. Vermont, Dominique A. Caugant, Germie van den Dobbelsteen	20
15	Relative Immunogenicity of PorA Subtypes in a Multivalent Neisseria meningitidis Vaccine Is Not Dependent on Presentation Form 2003 ·Infection and Immunity ·(unknown), Harry van Dijken, Hendrik-Jan Hamstra, Betsy Kuipers, Peter van der Ley, Loek van Alphen, Germie van den Dobbelsteen	18
16	Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine 2001 ·Vaccine ·Ester D. de Kleijn, (unknown), Clementien L. Vermont, Betsy Kuipers, Harry van Dijken, H. C. Rümke, Ronald de Groot, Loek van Alphen, Germie van den Dobbelsteen	44
17	Immunogenicity and safety of a hexavalent meningococcal outer-membrane-vesicle vaccine in children of 2–3 and 7–8 years of age 2000 ·Vaccine ·Ester D. de Kleijn, Ronald de Groot, Jerry Labadie, (unknown), Germie van den Dobbelsteen, Loek van Alphen, Harry van Dijken, Betsy Kuipers, (unknown), (unknown), (unknown), H. C. Rümke	117
18	A New Rat Model of Otitis Media Caused by Streptococcus pneumoniae : Conditions and Application in Immunization Protocols 1999 ·Infection and Immunity ·Leo T.M. van der Ven, Germie P. J. M. van den Dobbelsteen, Bhawani Nagarajah, Harry van Dijken, P.M. Dortant, Josephus G. Vos, Paul Roholl	21
19	Human B- and T-cell responses after immunization with a hexavalent PorA meningococcal outer membrane vesicle vaccine 1997 ·Infection and Immunity ·(unknown), Harry van Dijken, Betsy Kuipers, (unknown), Peter van der Ley, (unknown), Ivo Claassen, Jan Poolman	36
20	Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine 1996 ·Infection and Immunity ·(unknown), Peter van der Ley, (unknown), Suzanne George, (unknown), Harry van Dijken, Betsy Kuipers, Jan Poolman	97

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact